IBJNews

Covance plans $150M expansion, 465 jobs in Greenfield

Back to TopCommentsE-mailPrintBookmark and Share

Covance Inc. is seeking state and local tax incentives as part of a $150 million expansion that would create 465 jobs at its Greenfield operations, nearly doubling the number of employees at the location.

The proposed expansion would occur over the next four years and include the construction of a new laboratory, the renovation of existing buildings and improvements to infrastructure, according to the Daily Reporter in Greenfield.

Princeton, N.J.-based Covance, a pharmaceutical research company, acquired the Greenfield Labs from Eli Lilly and Co. in October 2008 for $50 million and a 10-year agreement from Lilly to use Covance’s services. At that time, 264 Lilly employees shifted to Covance. The company currently employs 565 workers at the site, according to the newspaper.

The Hancock County Council is set to hear Covance’s request for incentives July 11.

Documents filed with the county show the 465 jobs would add $29 million in salaries with annual pay averaging more than $62,000 per employee, the Daily Reporter said.

Covance is expected to hire for administrative and laboratory positions.

The company uses the Greenfield Laboratories to conduct early-stage tests of experimental drug molecules, readying them for tests in humans.
 

ADVERTISEMENT

  • Hearing Date
    Is the hearing date July 11 correct? I know things in Hancock County move slow, but that's a bit extreme. Is the hearing date January 11?

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT